» Articles » PMID: 11177118

A Separate Disease Within the Syndrome of Schizophrenia

Overview
Specialty Psychiatry
Date 2001 Feb 15
PMID 11177118
Citations 206
Authors
Affiliations
Soon will be listed here.
Abstract

If schizophrenia is a clinical syndrome rather than a single disease, the identification of specific diseases within the syndrome would facilitate the advance of knowledge and the development of more specific treatments. We propose that deficit psychopathology (ie, enduring, idiopathic negative symptoms) defines a group of patients with a disease different from schizophrenia without deficit features, as the deficit and nondeficit groups differ in their signs and symptoms, course, biological correlates, treatment response, and etiologic factors. These differences cannot be attributed to more severe positive psychotic symptoms or a greater duration of illness in the deficit group. The alternative interpretation that patients with deficit schizophrenia are at the severe end of a single disease continuum is not supported by risk factor and biological features data, but there is a need for independent replication of these findings. We suggest a series of studies designed to falsify one of these hypotheses, ie, multiple diseases vs a single disease.

Citing Articles

Physical illness in schizophrenia and the role of tolerability in antipsychotic selection: an expert consensus with a focus on cariprazine.

Cuomo A, Forleo G, Ghodhbane T, Johnsen J, Montejo A, Oliveira C Ann Gen Psychiatry. 2025; 24(1):13.

PMID: 40075512 PMC: 11905634. DOI: 10.1186/s12991-025-00550-4.


Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment.

Reznik A, Arbuzov A, Murin S Consort Psychiatr. 2024; 1(2):43-51.

PMID: 39006904 PMC: 11240126. DOI: 10.17650/2712-7672-2020-1-2-43-51.


Neural activity during inhibitory control predicts suicidal ideation with machine learning.

Nan J, Grennan G, Ravichandran S, Ramanathan D, Mishra J NPP Digit Psychiatry Neurosci. 2024; 2(1):10.

PMID: 38988507 PMC: 11230903. DOI: 10.1038/s44277-024-00012-x.


Prescription Digital Therapeutics: An Emerging Treatment Option for Negative Symptoms in Schizophrenia.

Fulford D, Marsch L, Pratap A Biol Psychiatry. 2024; 96(8):659-665.

PMID: 38960019 PMC: 11410508. DOI: 10.1016/j.biopsych.2024.06.026.


Topological Perturbations in the Functional Connectome Support the Deficit/Non-deficit Distinction in Antipsychotic Medication-Naïve First Episode Psychosis Patients.

Teles M, Maximo J, Lahti A, Kraguljac N Schizophr Bull. 2024; 50(4):839-847.

PMID: 38666705 PMC: 11283198. DOI: 10.1093/schbul/sbae054.